Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia
Open accessThe DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Abstract
In subjects with schizophrenia, impairments in working memory are associated with dysfunction of the dorsolateral prefrontal cortex (DLPFC). This dysfunction appears to be due, at least in part, to abnormalities in gamma-aminobutyric acid (GABA)-mediated inhibitory circuitry. To test the hypothesis that altered GABA-mediated circuitry in the DLPFC of subjects with schizophrenia reflects expression changes of genes that encode selective presynaptic and postsynaptic components of GABA neurotransmission, we conducted a systematic expression analysis of GABA-related transcripts in the DLPFC of 14 pairs of schizophrenia and age-, sex- and post-mortem interval-matched control subjects using a customized DNA microarray with enhanced sensitivity and specificity. Subjects with schizophrenia exhibited expression deficits in GABA-related transcripts encoding (1) presynaptic regulators of GABA neurotransmission (67 kDa isoform of glutamic acid decarboxylase (GAD(67)) and GABA transporter 1), (2) neuropeptides (somatostatin (SST), neuropeptide Y (NPY) and cholecystokinin (CCK)) and (3) GABA(A) receptor subunits (alpha1, alpha4, beta3, gamma2 and delta). Real-time qPCR and/or in situ hybridization confirmed the deficits for six representative transcripts tested in the same pairs and in an extended cohort, respectively. In contrast, GAD(67), SST and alpha1 subunit mRNA levels, as assessed by in situ hybridization, were not altered in the DLPFC of monkeys chronically exposed to antipsychotic medications. These findings suggest that schizophrenia is associated with alterations in inhibitory inputs from SST/NPY-containing and CCK-containing subpopulations of GABA neurons and in the signaling via certain GABA(A) receptors that mediate synaptic (phasic) or extrasynaptic (tonic) inhibition. In concert with previous findings, these data suggest that working memory dysfunction in schizophrenia is mediated by altered GABA neurotransmission in certain DLPFC microcircuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an expression analysis of DLPFC from SZ patients indicated the reduced expression of several GABA-related genes, including neuropeptides and both presynaptic and postsynaptic markers 183.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [183]
In the citing paper
“Despite variable results, consistent findings across studies can be identified, including dysregulation of GABAergic signalling102; downregulation of oligodendrocyte- and myelination-related genes103, mitochondrial function or energy metabolism104, and synaptic genes105; and upregulation of immune and inflammatory genes106.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [102]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Conflict monitoring and cognitive control
Botvinick, M. M., Braver, T. S., Barch, D. M., Carter, C. S., & Cohen, J. D. (2001) · Psychological Review · doi:10.1037/0033-295x.108.3.624 · Cited by 7,351
Applied Linear Statistical Models
(1997) · Technometrics · doi:10.1080/00401706.1997.10485141 · Cited by 7,185
Neurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Research works printed but not linked: 2
- Melchitzky DS, Lewis DA . Synaptic targets of somatostatin-labeled axon terminals in monkey prefrontal cortex. Soc Neurosci Abstr 2005; 675: 6.
- Kim AM, Matzilevich DA, Walsh JP, Benes FM, Woo TW . Parvalbumin-containing neurons and disturbances of prefrontal cortical circuitry in schizophrenia. Soc Neurosci Abstr 2005; 912: 1.
Cited by
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071
Self-citationModelling neural correlates of working memory: A coordinate-based meta-analysis
Rottschy, C., Langner, R., Dogan, I., Reetz, K., Laird, A. R., Schulz, J. B., Fox, P. T., & Eickhoff, S. B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.050 · Cited by 951
Gonzalez-Burgos, G., & Lewis, D. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn070 · Cited by 577
Self-citationShelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
Self-citationGABAergic interneuron origin of schizophrenia pathophysiology
Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., & Belforte, J. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.022 · Cited by 498
“A microarray study using postmortem dorsolateral PFC tissues of subjects with schizophrenia detected significant expression deficits of GABA-neuron-related-mRNAs, including mRNAs of the neuropeptides somatostatin, neuropeptide Y, and cholecystokinin (Hashimoto et al., 2008).”
BackgroundMeyer, U., Nyffeler, M., Yee, B. K., Knuesel, I., & Feldon, J. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.09.012 · Cited by 457
Hashimoto, T., Bazmi, H. H., Mirnics, K., Wu, Q., Sampson, A. R., & Lewis, D. A. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07081223 · Cited by 457
Self-citationSystems biology and gene networks in neurodevelopmental and neurodegenerative disorders
Parikshak, N. N., Gandal, M. J., & Geschwind, D. H. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3934 · Cited by 430
“Despite variable results, consistent findings across studies can be identified, including dysregulation of GABAergic signalling 102 ; downregulation of oligodendrocyte-and myelination-related genes 103 , mitochondrial function or energy metabolism 104 , and synaptic genes 105 ; and upregulation of…”
ResultYoon, J. H., Maddock, R. J., Rokem, A., Silver, M. A., Minzenberg, M. J., Ragland, J. D., & Carter, C. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6158-09.2010 · Cited by 408
“Histological studies have documented similar deficits in GABAergic markers in a number of cortical regions in schizophrenia (Hashimoto et al., 2008a).”
InfluentialComputational models of schizophrenia and dopamine modulation in the prefrontal cortex
Rolls, E. T., Loh, M., Deco, G., & Winterer, G. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2462 · Cited by 387
Ayalew, M., Le-Niculescu, H., Levey, D. F., Jain, N., Changala, B., Patel, S. D., Winiger, E., Breier, A., Shekhar, A., Amdur, R., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.37 · Cited by 397
Fuzik, J., Zeisel, A., Máté, Z., Calvigioni, D., Yanagawa, Y., Szabó, G., Linnarsson, S., & Harkany, T. (2016) · Nature Biotechnology · doi:10.1038/nbt.3443 · Cited by 386
Neuroplasticity of Neocortical Circuits in Schizophrenia
Lewis, D. A., & González-Burgos, G. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301563 · Cited by 365
Self-citationFung, S. J., Webster, M. J., Sivagnanasundaram, S., Duncan, C., Elashoff, M., & Weickert, C. S. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09060784 · Cited by 366
Bissonette, G. B., Martins, G. J., Franz, T. M., Harper, E. S., Schoenbaum, G., & Powell, E. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2820-08.2008 · Cited by 353
Bossong, M. G., & Niesink, R. J. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.010 · Cited by 333
Arion, D., Unger, T., Lewis, D. A., Levitt, P., & Mirnics, K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.021 · Cited by 329
Self-citationA Review of the Fetal Brain Cytokine Imbalance Hypothesis of Schizophrenia
Meyer, U., Feldon, J., & Yee, B. K. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn022 · Cited by 320
Neuroinflammation and white matter pathology in schizophrenia: systematic review
Najjar, S., & Pearlman, D. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.041 · Cited by 319
Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes
del Pino, I., García-Frigola, C., Dehorter, N., Brotons-Mas, J. R., Alvarez-Salvado, E., Martínez de Lagrán, M., Ciceri, G., Gabaldón, M. V., Moratal, D., Dierssen, M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.010 · Cited by 314
Yan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“Furthermore, expression analysis of DLPFC from SZ patients indicated the reduced expression of several GABA-related genes, including neuropeptides and both presynaptic and postsynaptic markers [183].”
BackgroundSpiteri, E., Konopka, G., Coppola, G., Bomar, J., Oldham, M., Ou, J., Vernes, S. C., Fisher, S. E., Ren, B., & Geschwind, D. H. (2007) · The American Journal of Human Genetics · doi:10.1086/522237 · Cited by 285
Curley, A. A., Arion, D., Volk, D. W., Asafu-Adjei, J. K., Sampson, A. R., Fish, K. N., & Lewis, D. A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010052 · Cited by 283
Self-citationAlterations in cortical interneurons and cognitive function in schizophrenia
Dienel, S. J., & Lewis, D. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.020 · Cited by 272
Self-citationMellios, N., Huang, H.-S., Baker, S. P., Galdzicka, M., Ginns, E., & Akbarian, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.019 · Cited by 266
Alterations of cortical GABA neurons and network oscillations in schizophrenia
Gonzalez-Burgos, G., Hashimoto, T., & Lewis, D. A. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0124-8 · Cited by 260
Self-citationCohen, S. M., Tsien, R. W., Goff, D. C., & Halassa, M. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.026 · Cited by 232
Neurodevelopment, GABA System Dysfunction, and Schizophrenia
Schmidt, M. J., & Mirnics, K. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.95 · Cited by 239
Self-citationLewis, D. A., & Sweet, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37335 · Cited by 233
Self-citationReduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
Eggan, S. M., Hashimoto, T., & Lewis, D. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.772 · Cited by 219
Self-citationBrain NMDA Receptors in Schizophrenia and Depression
Adell, A. (2020) · Biomolecules · doi:10.3390/biom10060947 · Cited by 212
Epigenetic Regulation in Human Brain—Focus on Histone Lysine Methylation
Akbarian, S., & Huang, H.-S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.015 · Cited by 214
Morris, H. M., Hashimoto, T., & Lewis, D. A. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm186 · Cited by 216
Self-citationLanz, T. A., Reinhart, V., Sheehan, M. J., Rizzo, S. J. S., Bove, S. E., James, L. C., Volfson, D., Lewis, D. A., & Kleiman, R. J. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0492-8 · Cited by 208
Self-citationMolecular profiles of schizophrenia in the CNS at different stages of illness
Narayan, S., Tang, B., Head, S. R., Gilmartin, T. J., Sutcliffe, J. G., Dean, B., & Thomas, E. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.023 · Cited by 207
Rethinking schizophrenia in the context of normal neurodevelopment
Catts, V. S., Fung, S. J., Long, L. E., Joshi, D., Vercammen, A., Allen, K. M., Fillman, S. G., Rothmond, D. A., Sinclair, D., Tiwari, Y., et al. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00060 · Cited by 206
GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies
de Jonge, J. C., Vinkers, C. H., Hulshoff Pol, H. E., & Marsman, A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00118 · Cited by 180
Canetta, S., Bolkan, S., Padilla-Coreano, N., Song, L. J., Sahn, R., Harrison, N. L., Gordon, J. A., Brown, A., & Kellendonk, C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.222 · Cited by 201
Thompson, M., Weickert, C. S., Wyatt, E., & Webster, M. J. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.02.005 · Cited by 185
Genetics and Function of Neocortical GABAergic Interneurons in Neurodevelopmental Disorders
Rossignol, E. (2011) · Neural Plasticity · doi:10.1155/2011/649325 · Cited by 188
Development of the GABAergic System from Birth to Adolescence
Kilb, W. (2012) · The Neuroscientist · doi:10.1177/1073858411422114 · Cited by 190
Abbas, A. I., Sundiang, M. J. M., Henoch, B., Morton, M. P., Bolkan, S. S., Park, A. J., Harris, A. Z., Kellendonk, C., & Gordon, J. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.029 · Cited by 183
Immune System Disturbances in Schizophrenia
Horváth, S., & Mirnics, K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.010 · Cited by 177
Self-citationExtracellular matrix abnormalities in schizophrenia
Berretta, S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.010 · Cited by 179
Arion, D., Corradi, J. P., Tang, S., Datta, D., Boothe, F., He, A., Cacace, A. M., Zaczek, R., Albright, C. F., Tseng, G., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.171 · Cited by 177
Self-citationThe regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain
Lee, S.-E., Lee, Y., & Lee, G. H. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01196-z · Cited by 170
Rissman, R. A., & Mobley, W. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07237.x · Cited by 172
The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders
Wen, T. H., Binder, D. K., Ethell, I. M., & Razak, K. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00270 · Cited by 170
Farzan, F., Barr, M. S., Levinson, A. J., Chen, R., Wong, W., Fitzgerald, P. B., & Daskalakis, Z. J. (2010) · Brain · doi:10.1093/brain/awq046 · Cited by 168
Duncan, C. E., Webster, M. J., Rothmond, D. A., Bahn, S., Elashoff, M., & Shannon Weickert, C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.12.007 · Cited by 169
Catts, V. S., Lai, Y. L., Weickert, C. S., Weickert, T. W., & Catts, S. V. (2015) · Biological Psychology · doi:10.1016/j.biopsycho.2015.10.013 · Cited by 183
Tada, M., Nagai, T., Kirihara, K., Koike, S., Suga, M., Araki, T., Kobayashi, T., & Kasai, K. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhu278 · Cited by 159
Deficits in Transcriptional Regulators of Cortical Parvalbumin Neurons in Schizophrenia
Volk, D. W., Matsubara, T., Li, S., Sengupta, E. J., Georgiev, D. D., Minabe, Y., Sampson, A. R., Hashimoto, T., & Lewis, D. A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030305 · Cited by 171
Self-citationNeural basis of psychosis-related behaviour in the infection model of schizophrenia
Meyer, U., & Feldon, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.022 · Cited by 158
Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions
Schulte, J. T., Wierenga, C. J., & Bruining, H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.05.001 · Cited by 161
Zhu, J., Zhuo, C., Xu, L., Liu, F., Qin, W., & Yu, C. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx051 · Cited by 160
Hashimoto, T., Nguyen, Q. L., Rotaru, D., Keenan, T., Arion, D., Beneyto, M., Gonzalez-Burgos, G., & Lewis, D. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.004 · Cited by 151
Self-citationUpper cortical layer–driven network impairment in schizophrenia
Batiuk, M. Y., Tyler, T., Dragičević, K., Mei, S., Rydbirk, R., Petukhov, V., Deviatiiarov, R. M., Sedmak, D., Frank, E., Feher, V., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn8367 · Cited by 161
Ayhan, Y., Abazyan, B., Nomura, J., Kim, R., Ladenheim, B., Krasnova, I. N., Sawa, A., Margolis, R. L., Cadet, J. L., Mori, S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.144 · Cited by 148
Hoftman, G. D., Volk, D. W., Bazmi, H. H., Li, S., Sampson, A. R., & Lewis, D. A. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt178 · Cited by 159
Self-citationGlausier, J. R., Fish, K. N., & Lewis, D. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.152 · Cited by 147
Self-citationGold, J. M., Hahn, B., Zhang, W. W., Robinson, B. M., Kappenman, E. S., Beck, V. M., & Luck, S. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.65 · Cited by 144
Tseng, K. Y., Lewis, B. L., Hashimoto, T., Sesack, S. R., Kloc, M., Lewis, D. A., & O'Donnell, P. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4166-08.2008 · Cited by 144
Self-citationReversal of Behavioral Deficits and Synaptic Dysfunction in Mice Overexpressing Neuregulin 1
Yin, D., Chen, Y., Lu, Y.-S., Bean, J. C., Sathyamurthy, A., Shen, C., Liu, X., Lin, T. W., Smith, C. A., Xiong, W., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.028 · Cited by 155
Jaaro-Peled, H., Ayhan, Y., Pletnikov, M. V., & Sawa, A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp133 · Cited by 154
Boy, F., Evans, J., Edden, R. A. E., Lawrence, A. D., Singh, K. D., Husain, M., & Sumner, P. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.030 · Cited by 151
Target Identification for CNS Diseases by Transcriptional Profiling
Altar, C. A., Vawter, M. P., & Ginsberg, S. D. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.172 · Cited by 152
Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia
Volk, D. W., Chitrapu, A., Edelson, J. R., Roman, K. M., Moroco, A. E., & Lewis, D. A. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15010019 · Cited by 151
Self-citationCortical basket cell dysfunction in schizophrenia
Curley, A. A., & Lewis, D. A. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224659 · Cited by 136
Self-citationWang, A. Y., Lohmann, K. M., Yang, C. K., Zimmerman, E. I., Pantazopoulos, H., Herring, N., Berretta, S., Heckers, S., & Konradi, C. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0881-4 · Cited by 135
Developmental Dysfunction of VIP Interneurons Impairs Cortical Circuits
Batista-Brito, R., Vinck, M., Ferguson, K. A., Chang, J. T., Laubender, D., Lur, G., Mossner, J. M., Hernandez, V. G., Ramakrishnan, C., Deisseroth, K., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.034 · Cited by 135
GABA abnormalities in schizophrenia: A methodological review of in vivo studies
Taylor, S. F., & Tso, I. F. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.011 · Cited by 137
Synaptic changes in the brain of subjects with schizophrenia
Faludi, G., & Mirnics, K. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.02.013 · Cited by 154
Self-citationCharych, E. I., Liu, F., Moss, S. J., & Brandon, N. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.027 · Cited by 143
Hill, A. T., Rogasch, N. C., Fitzgerald, P. B., & Hoy, K. E. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.006 · Cited by 144
Yoon, J. H., Grandelis, A., & Maddock, R. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1970-16.2016 · Cited by 141
Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia
Jadi, M. P., Behrens, M. M., & B, T. J. S. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.005 · Cited by 137
Merner, N. D., Chandler, M. R., Bourassa, C. V., Liang, B., Khanna, A. R., Dion, P. A., Rouleau, G. A., & Kahle, K. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00386 · Cited by 141
Development of Patient-Specific Neurons in Schizophrenia Using Induced Pluripotent Stem Cells
Pedrosa, E., Sandler, V. M., Shah, A., Carroll, R. C., Chang, C.-J., Rockowitz, S., Guo, X., Zheng, D., & Lachman, H. M. (2011) · Journal of Neurogenetics · doi:10.3109/01677063.2011.597908 · Cited by 137
Arion, D., & Lewis, D. A. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.114 · Cited by 141
Self-citationHoftman, G. D., & Lewis, D. A. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr029 · Cited by 138
Self-citationIn Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders
Pantazopoulos, H., & Berretta, S. (2015) · Neural Plasticity · doi:10.1155/2016/9847696 · Cited by 136
Neuroplasticity in Depressed Individuals Compared with Healthy Controls
Player, M. J., Taylor, J. L., Weickert, C. S., Alonzo, A., Sachdev, P., Martin, D., Mitchell, P. B., & Loo, C. K. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.126 · Cited by 127
Nikulin, V. V., Jönsson, E. G., & Brismar, T. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.008 · Cited by 137
Renard, J., Szkudlarek, H. J., Kramar, C. P., Jobson, C. E. L., Moura, K., Rushlow, W. J., & Laviolette, S. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11645-8 · Cited by 125
Fatemi, S. H., Folsom, T. D., Rooney, R. J., & THURAS, P. D. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.64 · Cited by 128
Yang, Y., Fung, S. J., Rothwell, A. R., Si, T., & Weickert, C. S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.020 · Cited by 128
Histone modifications, DNA methylation, and Schizophrenia
Gavin, D. P., & Sharma, R. P. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.010 · Cited by 121
Lamina-Specific Alterations in Cortical GABAA Receptor Subunit Expression in Schizophrenia
Beneyto, M., Abbott, A., Hashimoto, T., & Lewis, D. A. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq169 · Cited by 132
Self-citationThe emerging role of microRNAs in schizophrenia and autism spectrum disorders
Mellios, N., & Sur, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00039 · Cited by 120
Stedehouder, J., & Kushner, S. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.147 · Cited by 126
Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia
Mohammadi, A., Rashidi, E., & Amooeian, V. G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.036 · Cited by 122
Volk, D. W., Eggan, S. M., & Lewis, D. A. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030318 · Cited by 126
Self-citationTheranostic Biomarkers for Schizophrenia
Perković, M. N., Erjavec, G. N., Štrac, D. Š., Uzun, S., Kozumplik, O., & Pivac, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040733 · Cited by 123
Selection of Reference Gene Expression in a Schizophrenia Brain Cohort
Weickert, C. S., Sheedy, D. L., Rothmond, D. A., Dedova, I. V., Fung, S. J., Garrick, T. M., Wong, J., Harding, A. J., Sivagnanansundaram, S., Hunt, C. E., et al. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903393662 · Cited by 111
Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia
Enwright III, J. F., Huo, Z., Arion, D., Corradi, J. P., Tseng, G., & Lewis, D. A. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.216 · Cited by 109
Self-citationDiurnal rhythms in gene expression in the prefrontal cortex in schizophrenia
Seney, M. L., Cahill, K., Enwright, J. F., Logan, R. W., Huo, Z., Zong, W., Tseng, G., & McClung, C. A. (2019) · Nature Communications · doi:10.1038/s41467-019-11335-1 · Cited by 108
Sommer, W. H., Lidström, J., Sun, H., Passer, D., Eskay, R. L., Parker, S. C. J., Witt, S. H., Zimmermann, U. S., Nieratschker, V., Rietschel, M., et al. (2010) · Human Mutation · doi:10.1002/humu.21299 · Cited by 108
Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes
Brown, J. A., Ramikie, T. S., Schmidt, M. J., Báldi, R., Garbett, K. A., Everheart, M., Warren, L. E., Gellért, L., Horváth, S., Patel, S., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.192 · Cited by 115
Self-citation
Metadata
- Authors
- Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Lewis, D A
- Venue
- Molecular Psychiatry
- Published
- 2007-05-01
- Volume
- 13
- Issue
- 2
- Pages
- 147-161
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2882638
- OpenAlex
- W2126843605
- Cited by
- 490
- References
- 262
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 17 · 2023: 17 · 2022: 15 · 2021: 24 · 2020: 29 · 2019: 22 · 2018: 26 · 2017: 25 · 2016: 33 · 2015: 42 · 2014: 25 · 2013: 29 · 2012: 27
- FWCI
- 20.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Eli Lilly and Company
- National Institutes of Health
- Medical Center, University of Pittsburgh
- National Institute of Mental Health (R01MH043784, MH43784, MH 45156, MH-067234, MH070786, K02MH070786, R01MH067234, P50MH045156, R37MH043784)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD015052)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, dorsolateral prefrontal cortex, GABAergic neurotransmission, gene expression, working memory, GAD67, GABA transporter 1, somatostatin, neuropeptide Y, cholecystokinin, GABAA receptor subunits, presynaptic inhibition, tonic inhibition, antipsychotic exposure, inhibitory interneurons
- MeSH terms
- Olanzapine, Adult, Aged, Animals, Benzodiazepines, Chloroquinolinols, Female, Gene Expression Regulation, Glutamate Decarboxylase, Humans, Macaca fascicularis, Male, Middle Aged, Neuropeptides, Receptors, GABA-A, Schizophrenia, Antipsychotic Agents, Case-Control Studies, Prefrontal Cortex, Oligonucleotide Array Sequence Analysis, Protein Subunits, GABA Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.